{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:18:04Z","timestamp":1787840284322,"version":"build-2784847793"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective\/Background:<\/jats:title>\n                    <jats:p>There are several methods used to screen for latent tuberculosis (TB) infection (LTBI) including the QuantiFERON-TB Gold-in-Tube (QFT-GIT) and T-SPOT-TB (T-SPOT) tests. Many studies have reported the equivalence of these two methods, but it is unclear which of them is more cost effective. We investigated the age and cost issues of these tests in screening for LTBI among health-care workers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>One hundred and forty new employees during 2008\u20132011 in our hospital were screened using the QFT-GIT test, and 140 new employees during 2011\u20132014 were screened with the T-SPOT test for LTBI. The results of both tests were classified as positive, undetermined (retesting required), or negative.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      There were six positive results (4.29%), eight undetermined results (5.71%), and 126 negative results (90.0%) with the QFT-GIT test. As for the T-SPOT test, there were eight positive results (5.71%), three undetermined results (2.14%), and 129 negative results (92.1%). Fourteen LTBI employees (6 in QFT-GIT and 8 in T-SPOT) were detected statistically equally using the two methods (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.79). The total costs, including those incurred for retesting, were $7,711.86 (US dollar) and $6,525.42 for the QFT-GIT and T-SPOT tests (cost of one test is $55.08 for QFT-GIT and $46.61 for T-SPOT), respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>T-SPOT is one of the options for screening for LTBI partly owing to the viewpoint of cost-effectiveness. Further prospective studies need to be considered for a definitive conclusion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/2212-5531.201899","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T11:07:10Z","timestamp":1495105630000},"page":"83-86","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of Cost-effectiveness between the QuantiFERON-TB Gold-In-Tube and T-Spot Tests for Screening Health-care Workers for Latent Tuberculosis Infection"],"prefix":"10.4103","volume":"6","author":[{"given":"Shigeto","family":"Mukai","sequence":"first","affiliation":[{"name":"Infection Control Team, Hyogo Prefectural Rehabilitation Central Hospital, Sanda, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Shigemura","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgery Related, Kobe University Graduate School of Medicine, Kobe, Japan"},{"name":"Department of International Health, Kobe University Graduate School of Health Science, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fukashi","family":"Yamamichi","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgery Related, Kobe University Graduate School of Medicine, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kitagawa","sequence":"additional","affiliation":[{"name":"Division of Translational Research for Biologics, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Takami","sequence":"additional","affiliation":[{"name":"Infection Control Team, Hyogo Prefectural Rehabilitation Central Hospital, Sanda, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Nomi","sequence":"additional","affiliation":[{"name":"Infection Control Team, Hyogo Prefectural Rehabilitation Central Hospital, Sanda, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichi","family":"Arakawa","sequence":"additional","affiliation":[{"name":"Department of Urology, Sanda Municipal Hospital, Sanda, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Fujisawa","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgery Related, Kobe University Graduate School of Medicine, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/archdischild-2013-303641","article-title":"How to use: Interferon \u03b3 release assays for tuberculosis","volume":"98","author":"Pollock","year":"2013","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.5588\/ijtld.11.0829","article-title":"Comparison of specificities between two interferon-gamma release assays in Japan","volume":"16","author":"Higuchi","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"R3-20250603","first-page":"33","article-title":"Guidelines for using QuantiFERON TB Gold in-tube","volume":"88","year":"2013","journal-title":"Kekkaku"},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s15010-012-0394-7","article-title":"Predictive factors for tuberculosis in patients with a TB-PCR-negative bronchial aspirate","volume":"41","author":"Kim","year":"2013","journal-title":"Infection"},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.201302-0365OC","article-title":"Interferon-\u03b3 release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States","volume":"189","author":"Dorman","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3109\/14397595.2016.1149267","article-title":"A comparative analysis of two interferon-\u03b3 releasing assays to detect past tuberculosis infections in Japanese rheumatoid arthritis patients","volume":"26","author":"Iwagaitsu","year":"2016","journal-title":"Mod Rheumatol"},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3947\/ic.2013.45.1.44","article-title":"Indeterminate T-SPOT.TB test results in patients with suspected extrapulmonary tuberculosis in routine clinical practice","volume":"45","author":"Lee","year":"2013","journal-title":"Infect Chemother"},{"key":"R10-20250603","first-page":"655","article-title":"Comparison of tests results between T-SPOT.TB and QuantiFERON-TB Gold In-Tube in a contact investigation","volume":"89","author":"Mukouyama","year":"2014","journal-title":"Kekkaku"},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200402-179OC","article-title":"Specific detection of tuberculosis infection: An interferon-gamma-based assay using new antigens","volume":"170","author":"Mori","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1183\/09031936.00028507","article-title":"Quantitative scoring of an interferon-gamma assay for differentiating active from latent tuberculosis","volume":"30","author":"Janssens","year":"2007","journal-title":"Eur Respir J"},{"key":"R16-20250603","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.trstmh.2005.05.023","article-title":"Gender, equity: New approaches for effective management of communicable diseases","volume":"100","author":"Theobald","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R17-20250603","first-page":"549","article-title":"Tuberculosis control strategy in the 21st century in Japan \u2013 For elimination of tuberculosis in Japan","volume":"76","author":"Aoki","year":"2001","journal-title":"Kekkaku"},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.vaccine.2013.04.089","article-title":"Current situation of tuberculosis in Japan and requirement for new vaccine","volume":"32","author":"Mitarai","year":"2014","journal-title":"Vaccine"},{"key":"R19-20250603","first-page":"811","article-title":"Evaluation of the tuberculosis control program through tuberculosis surveillance","volume":"83","author":"Ohmori","year":"2008","journal-title":"Kekkaku"},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1080\/00365540601148483","article-title":"Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific IFN-gamma whole-blood test","volume":"39","author":"Soborg","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF03256289","article-title":"Cost effectiveness of interferon-gamma release assay for tuberculosis contact screening in Japan","volume":"12","author":"Kowada","year":"2008","journal-title":"Mol Diagn Ther"},{"key":"R22-20250603","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/j.ajkd.2012.07.019","article-title":"Tests for latent tuberculosis in people with ESRD: A systematic review","volume":"61","author":"Rogerson","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"R24-20250603","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/1471-2334-10-348","article-title":"IFN-\u03b3 response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection","volume":"10","author":"Latorre","year":"2010","journal-title":"BMC Infect Dis"},{"key":"R25-20250603","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1586\/17476348.2.2.253","article-title":"Using ELISpot technology to improve the diagnosis of tuberculosis infection: From the bench to the T-SPOT.TB assay","volume":"2","author":"Richeldi","year":"2008","journal-title":"Expert Rev Respir Med"},{"key":"R26-20250603","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00430-008-0102-5","article-title":"Comparison of performance in two diagnostic methods for tuberculosis infection","volume":"198","author":"Higuchi","year":"2009","journal-title":"Med Microbiol Immunol"},{"key":"R27-20250603","doi-asserted-by":"crossref","first-page":"e0156917","DOI":"10.1371\/journal.pone.0156917","article-title":"Comparison of the sensitivity of QuantiFERON-TB Gold In-Tube and T-SPOT.TB according to patient age","volume":"11","author":"Bae","year":"2016","journal-title":"PLoS One"},{"key":"R28-20250603","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1183\/09031936.00145906","article-title":"Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis","volume":"30","author":"Diel","year":"2007","journal-title":"Eur Respir J"},{"key":"R29-20250603","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2466-10-7","article-title":"Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: A cost effectiveness analysis","volume":"10","author":"Pooran","year":"2010","journal-title":"BMC Pulm Med"}],"container-title":["The International Journal of Mycobacteriology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01929415-201706010-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:19:22Z","timestamp":1787836762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01929415-201706010-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4103\/2212-5531.201899","relation":{},"ISSN":["2212-5531","2212-554X"],"issn-type":[{"value":"2212-5531","type":"print"},{"value":"2212-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}